JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CRNX
3301
DELISTED
Crinetics Pharmaceuticals
CRNX
| $3.31M | ﹤0.01% |
93,104
+38,674
| +71% | +$1.19M |
2018 Q3
21 quarters
|
|
3302
Caribou Biosciences
CRBU
$131M
| $3.31M | ﹤0.01% |
576,984
+4,606
| +0.8% | +$22.8K |
2021 Q3
9 quarters
|
|
|
INN
3303
Summit Hotel Properties
INN
$649M
| $3.3M | ﹤0.01% |
491,575
-441,719
| -47% | -$2.72M |
2014 Q3
37 quarters
|
|
3304
Resources Connection
RGP
$134M
| $3.3M | ﹤0.01% |
232,720
+14,891
| +7% | +$208K |
2013 Q2
42 quarters
|
|
|
KW
3305
DELISTED
Kennedy-Wilson Holdings
KW
| $3.29M | ﹤0.01% |
265,872
-459,739
| -63% | -$5.76M |
2015 Q1
35 quarters
|
|
3306
ProPetro Holding
PUMP
$1.14B
| $3.29M | ﹤0.01% |
392,637
-5,310
| -1% | -$50.1K |
2017 Q1
27 quarters
|
|
|
FL
3307
CALL
DELISTED
Foot Locker
FL
| $3.29M | ﹤0.01% |
105,500
+105,400
| +105,400% | +$2.54M |
2023 Q1
3 quarters
|
|
3308
BioCryst Pharmaceuticals
BCRX
$2.09B
| $3.28M | ﹤0.01% |
547,537
-60,978
| -10% | -$353K |
2017 Q4
24 quarters
|
|
3309
PUT
Revvity
RVTY
$16.9B
| $3.28M | ﹤0.01% |
+30,000
| New | +$2.89M |
2023 Q4
0 quarters
|
|
|
FBRT
3310
Franklin BSP Realty Trust
FBRT
$521M
| $3.27M | ﹤0.01% |
242,235
+32,495
| +15% | +$428K |
2021 Q4
8 quarters
|
|
3311
GrafTech
EAF
$246M
| $3.27M | ﹤0.01% |
149,224
+103,358
| +225% | +$2.92M |
2018 Q2
22 quarters
|
|
3312
iShares US Financials ETF
IYF
$3.92B
| $3.25M | ﹤0.01% |
38,010
+15,438
| +68% | +$1.2M |
2013 Q2
42 quarters
|
|
3313
Dillards
DDS
$10.2B
| $3.25M | ﹤0.01% |
8,040
-884
| -10% | -$300K |
2013 Q2
42 quarters
|
|
3314
CALL
CoStar Group
CSGP
$11.1B
| $3.24M | ﹤0.01% |
+37,100
| New | +$3M |
2023 Q4
0 quarters
|
|
3315
JPMorgan Municipal ETF
JMUB
$8.21B
| $3.24M | ﹤0.01% |
63,545
+37,589
| +145% | +$1.85M |
2023 Q3
1 quarter
|
|
3316
CALL
Amplify Junior Silver Miners ETF
SILJ
$3.55B
| $3.24M | ﹤0.01% |
322,300
| – | – |
2023 Q2
2 quarters
|
|
3317
iShares Fallen Angels USD Bond ETF
FALN
$1.56B
| $3.24M | ﹤0.01% |
122,586
+82,469
| +206% | +$2.08M |
2022 Q1
7 quarters
|
|
3318
Veracyte
VCYT
$3.68B
| $3.23M | ﹤0.01% |
117,243
-143,623
| -55% | -$3.47M |
2017 Q3
25 quarters
|
|
|
LBPH
3319
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $3.22M | ﹤0.01% |
534,716
+1,214
| +0.2% | +$6.05K |
2023 Q2
2 quarters
|
|
3320
CALL
Nutrien
NTR
$33.4B
| $3.22M | ﹤0.01% |
57,200
+56,100
| +5,100% | +$3.17M |
2023 Q3
1 quarter
|
|
3321
Alkami Technology
ALKT
$1.49B
| $3.22M | ﹤0.01% |
132,671
-8,468
| -6% | -$177K |
2021 Q2
10 quarters
|
|
3322
Myers Industries
MYE
$1.19B
| $3.22M | ﹤0.01% |
164,513
+25,625
| +18% | +$456K |
2013 Q2
42 quarters
|
|
|
CCLP
3323
DELISTED
CSI Compressco LP
CCLP
| $3.21M | ﹤0.01% |
1,969,019
+422,730
| +27% | +$633K |
2022 Q4
4 quarters
|
|
3324
ArcelorMittal
MT
$48.5B
| $3.21M | ﹤0.01% |
112,900
+17,653
| +19% | +$432K |
2013 Q2
42 quarters
|
|
3325
Ameresco
AMRC
$1.14B
| $3.2M | ﹤0.01% |
101,183
+45,469
| +82% | +$1.37M |
2017 Q4
24 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.